This site is only for use by healthcare professionals. By continuing to view this site you are confirming that you are a healthcare professional.

Share
Stay up to date

Home
Topics
Webinars/Videos
Infographics
Articles
Case Studies
Forum
Faculty
Unblocked
Stay up to date

Articles

Oral PCSK9 Inhibitors

Agarwala A, Asim R, Ballantyne CM

Journal:

Curr Atheroscler Rep

First published: March 13, 2024 DOI: 10.1007/s11883-024-01199-2

Abstract

You might also like...

Running time: 17 minutes
Webinars/Videos
Highlights from ESC Congress 2021: Part Two
In this second video from the ESC 2021, Professor Cannon and Professor Nicholls discuss late-breaking results from the HUGYENs trial on evolcoumab, as well as the ESC prevention guidelines and the impact of the NHS approval of Inclisiran in improving patient care.
Agarwala A, Asim R, Ballantyne CM
Journal:
Curr Atheroscler Rep

First published: March 13, 2024 DOI: 10.1007/s11883-024-01199-2
View
- Share
Infographics
Spotlight on Homozygous Familial Hypercholesterolemia
In this infographic, we look at current treatment strategies and future innovations.
Agarwala A, Asim R, Ballantyne CM
Journal:
Curr Atheroscler Rep

First published: March 13, 2024 DOI: 10.1007/s11883-024-01199-2
View
- Share
Case Studies
Quiz of the month – May 2022
Take this short quiz to test your knowledge on some of the latest peer-reviewed published literature related to ASCVD and Lipidology.
Agarwala A, Asim R, Ballantyne CM
Journal:
Curr Atheroscler Rep

First published: March 13, 2024 DOI: 10.1007/s11883-024-01199-2
Take
- Share

How would you rate this content?

© John Wiley & Sons, Ltd. All rights reserved.
Privacy Policy
Terms of use
Stay up to date
Cookie Preferences
This Knowledge Hub is supported by Novartis.